PMID: 9161791Mar 1, 1997Paper

Adoptive immunotherapy with donor lymphocyte transfusions

Current Opinion in Oncology
H J Kolb, E Holler

Abstract

Adoptive immunotherapy denotes the transfer of immunocompetent cells for the treatment of leukemia, cancer, or viral disease. It has regained much interest through the success of treating recurrent leukemia after allogeneic bone marrow transplantation with the transfusion of donor lymphocytes. Chimerism and transplantation tolerance toward the donor offer the possibility of adoptive immunotherapy using donor lymphocytes. In animal studies, donor lymphocytes could be transfused into the chimeric animal, if the transfusion was delayed after marrow transplantation. Transfused lymphocytes exhibit a graft-versus-leukemia effect and increase chimerism. Immunity could be transferred and immune reactivity toward new antigens improved. In human patients transfusion of donor lymphocytes was studied in leukemia recurring after marrow transplantation. It was very effective in the treatment of chronic myelogenous leukemia recurring after marrow transplantation. It was also effective in some patients with acute myeloid leukemia, myelodysplastic syndrome and myeloma; in acute lymphoblastic leukemia and lymphoma responses were rare. Responses in solid tumors as breast cancer have been described. Major complications are graft-versus-host diseas...Continue Reading

Citations

Jun 12, 2003·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·P TiberghienP Hervé
Apr 12, 2001·Journal of Internal Medicine·M K Brenner
May 2, 2002·Journal of Hematotherapy & Stem Cell Research·F Baron, Y Beguin
Oct 24, 2002·Current Opinion in Hematology·Jeffrey J MolldremEric Wieder
Jan 13, 2004·Genetic Vaccines and Therapy·Frank SchakowskiIngo GH Schmidt-Wolf
Apr 30, 2005·Journal of Translational Medicine·Cassian Yee
Nov 5, 2011·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Lawrence G Lum, Archana Thakur
Sep 1, 2008·Expert Opinion on Drug Discovery·Lawrence G Lum, Zaid Al-Kadhimi
Mar 24, 2010·Pediatric Clinics of North America·Terry J FryPeter Bader
Mar 14, 2009·Lancet·James L M FerraraErnst Holler
Sep 16, 2008·Best Practice & Research. Clinical Haematology·Tao Dao, David A Scheinberg
Apr 14, 2006·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Baolin LiuZhiguang Guo
Mar 10, 2001·Journal of Chemotherapy·F F Fagnoni, G Robustelli della Cuna
Jul 24, 2004·Hematology/oncology Clinics of North America·Dax Kurbegov, Jeffrey J Molldrem
Feb 13, 2003·Pediatric Clinics of North America·Robert J Arceci, Timothy P Cripe
Sep 21, 2007·Cytotherapy·M P CollinM Merad
Oct 25, 2002·Cytotherapy·J J Molldrem
Dec 12, 2002·Oncogene·Jeffrey J MolldremSijie Lu
Jan 9, 1999·Immunity·J A Sogn
Feb 15, 2011·Seminars in Immunology·Daigo Hashimoto, Miriam Merad
Jan 10, 2006·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Jeffrey J Molldrem
Oct 24, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Raimon Duran-StruuckPavan Reddy
Jan 24, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Liesbeth E M OostenEls Goulmy
Nov 10, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Sharon L GardnerHideho Okada
Dec 5, 2000·Baillière's Best Practice & Research. Clinical Haematology·J H Lee, H G Klein
Apr 11, 2007·Advances in Cancer Research·Olle Ringdén
Nov 23, 2017·The New England Journal of Medicine·Jeremy S Abramson, Yi-Bin Chen
Apr 4, 2001·Pediatrics International : Official Journal of the Japan Pediatric Society·A ShibuyaN Sasaki
May 23, 2001·Leukemia·M P VeldersW M Kast

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.